Praxis Precision Medicines (PRAX) Tops Q2 EPS by 367c

August 6, 2026 8:20 AM EDT

Praxis Precision Medicines (NASDAQ: PRAX) reported Q2 EPS of $0.00, $3.67 better than the analyst estimate of ($3.67).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK